Predictive Oncology
POAI
POAI
15 hedge funds and large institutions have $1.21M invested in Predictive Oncology in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Holders
15
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$378K | |
| 2 | +$39.2K | |
| 3 | +$16.5K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$14.7K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.22K |
Top Sellers
| 1 | -$6.38K | |
| 2 | -$4.6K | |
| 3 | -$2.13K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$622 |